Knott David M Jr Horizon Therapeutics Public LTD CO Transaction History

Knott David M Jr

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$96.34 - $112.38 $1.38 Million - $1.61 Million	-14,300 Reduced 34.47%	27,190 $2.8 Million
Q1 2023 May 11, 2023	BUY	$107.32 - $113.5 $107,320 - $113,500	1,000 Added 2.47%	41,490 $4.53 Million
Q4 2022 Feb 13, 2023	SELL	$62.39 - $113.8 $187,170 - $341,400	-3,000 Reduced 6.9%	40,490 $4.61 Million
Q2 2022 Aug 11, 2022	BUY	$79.4 - $116.36 $794,000 - $1.16 Million	10,000 Added 29.86%	43,490 $3.47 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $1.25 Million - $1.59 Million	14,490 Added 76.26%	33,490 $3.53 Million
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $1.87 Million - $2.28 Million	19,000 New	19,000 $2.05 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.